Liquidia (LQDA) FCF Margin (QoQ) (2021 - 2026)
Liquidia (LQDA) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Liquidia | 6.34 Bn | 6.05 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 746.00 |
| Mar 31, 2026 | -1,320.00 |
| Dec 31, 2025 | 6,778.00 |
| Sep 30, 2025 | 39,048.00 |
| Jun 30, 2025 | 72,137.00 |
| Mar 31, 2025 | -53,631.00 |
| Dec 31, 2024 | 3,675.00 |
| Sep 30, 2024 | -1,678.00 |
| Jun 30, 2024 | 24,795.00 |
| Mar 31, 2024 | -50,585.00 |
| Dec 31, 2023 | -3,003.00 |
| Sep 30, 2023 | -20,591.00 |
| Jun 30, 2023 | 7,504.00 |
| Mar 31, 2023 | -10,133.00 |
| Dec 31, 2022 | 9,037.00 |
| Sep 30, 2022 | 3,001.00 |
| Jun 30, 2022 | 6,460.00 |
| Mar 31, 2022 | -4,427.00 |
| Dec 31, 2021 | -5,232.00 |
| Sep 30, 2021 | 6,495.00 |